Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:19 AM
Ignite Modification Date:
2025-12-25 @ 12:19 AM
NCT ID:
NCT06919458
Eligibility Criteria:
Inclusion Criteria:
* Patients with AAH aged between 18 and 80 years with a MELD score \>21 and/or mDF \>32 will be included.
* Patients with infection at baseline will be included if they have controlled infection defined as afebrile for at least 48 hours, sterile cultures and procalcitonin \< 1 ng/ml.
Exclusion Criteria:
* Age \< 18 years, \> 80 years
* Active Infection
* Persistent acute kidney injury (creatinine \>1.5 mg/dl) or chronic kidney disease
* Recent/ongoing bleed
* Active peptic ulcer disease
* Hepatocellular carcinoma, portal vein thrombosis or hepatic venous outflow tract obstruction
* Patients with concomitant other liver diseases including hepatitis B, C
* Patients with HIV
* Uncontrolled diabetes mellitus
* Patients on pentoxifylline or NAC
* Patients who are unwilling
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT06919458
Study Brief:
Protocol Section:
NCT06919458